Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga diabetes study

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 813-819

  Cavalot, F ^a   Petrelli, A ^a   Traversa, M ^a   Bonomo, K ^a   Fiora, E ^a   Conti, M ^a   Anfossi, G ^a   Costa, G ^a   Trovati, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; DISEASE DURATION; FASTING BLOOD GLUCOSE; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL BLOOD GLUCOSE; POSTPRANDIAL STATE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; SEX CHARACTERISTICS;

EID: 33644832167     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1005     Document Type: Article

References (40)

1. Laakso M, Lehto S 1997 Epidemiology of macrovascular disease in diabetes. Diabetes Rev 5:294-315
2. Stamler J, Vaccaro O, Necton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Risk Group 1993 Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444
3. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J 1986 Relationships of clinical diabetes and symptomatic hyperglycaemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516
4. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL 1991 Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265:627-631
5. Wilson PWF, Cupples LA, Kannel WB 1991 Is hyperglycaemia associated with cardiovascular disease? The Framingham Study. Am Heart J 121:586-590
6. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ 1999 Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 42:926-931
7. DECODE Study Group 2001 Glucose tolerance and cardiovascular mortality: comparison of the fasting and the 2-hour diagnostic criteria. Arch Intern Med 161:397-404
8. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL 2001 Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24:1397-1402
9. Coutinho M, Gerstein H, Poque J, Wang Y, Yusuf S 1999 The relationship between glucose and incident cardiovascular events: a meta regression analysis of published data from 20 studies of 95.783 individuals followed for 12.4 years. Diabetes Care 22:233-240
10. Laakso M 1999 Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942
11. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J 1996 Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583
12. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R 1996 Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39:1540-1545
13. Haffner S 1998 The importance of hyperglycemia in the non fasting state to the development of cardiovascular disease. Endocr Rev 19:583-592
14. Bonora E, Muggeo M 2001 Postprandial blood glucose as a risk factor for cardiovascular disease in type 2 diabetes: the epidemiological evidence. Diabetologia 44:2107-2114
15. Heine RJ, Dekker JM 2002 Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 45:461-475
16. Gerich JE 2003 Clinical significance, pathogenesis and management of postprandial hyperglycemia. Arch Intern Med 163:1306-1316
17. Yudkin JS 2002 Post-load hyperglycaemia-an inappropriate therapeutic target. Lancet 359:166-167
18. American Diabetes Association 2001 Consensus statement: postprandial blood glucose. Diabetes Care 24:775-778
19. Jackson R, Chambless L, Higgins M, Kuulasmaa K, Wijnberg L, Williams D 1997 WHO Monica Project, and ARIC Study sex difference in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis. Cardiovasc Risk Factors 7:43-54
20. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation 99:1165-1172
21. Janghorbani M, Jones RB, Gilmour WH, Hedley AJ, Zhianpour M 1994 A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycaemics. J Clin Invest 47:397-405
22. Orchard TJ 1996 The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 28:323-333
23. Lee WL, Cheung AM, Cape D, Zinman B 2000 Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23:962-968
24. Kanaya AM, Grady D, Barrett-Connor E 2002 Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162:1737-1745
25. DECODE Study Group 2003 Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608-617
26. National Diabetes Data Group 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
27. Trovati M, Burzacca S, Mularoni E, Massucco P, Cavalot F, Mattiello L, Anfossi G 1991 Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. Diabetologia 34:662-667
28. Ministero della Sanità, Dipartimento della Programmazione 1998 Classificazione delle malattie, dei traumatismi, degli interventi chirurgici e delle procedure diagnostiche e terapeutiche. Italian Version of ICD-9-CM (International Classification of Diseases, 9th revision, Clinical Modification)-1997. Rome: Istituto Poligrafico e Zecca dello Stato, Libreria dello Stato
29. Cochran WG and Cox GM 1950 Experimental designs. New York: Wiley & Sons
30. Collett D 1994 Modelling survival data in medical research. London: Chapman and Hall
31. Trovati M, Ponziani MC, Massucco P, Anfossi G, Mularoni EM, Burzacca S, Tassone F, Perna P, Traversa M, Cavalot F 2002 Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest 32:179-186
32. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R 1997 Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 96:1750-1754
33. Temelkova-Kurktschiev T, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M 2000 Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23:1830-1834
34. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group 2003 Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486-494
35. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M 2004 Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10-16
36. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T 2004 Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 35:1073-1078
37. Esposito K, Giugliano D, Nappo F, Marfella R for the Campanian Postprandial Hyperglycemia Study Group 2004 Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214-219
38. Ceriello A 2003 The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46(Suppl 1):M9-M16
39. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J 2004 Postprandial glucose regulation and diabetic complications. Arch Intern Med 19:2090-2095
40. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen HR 2004 What does postprandial hyperglycaemia mean? Diabetic Med 21:208-213